Filter
42
Filtered Results: 42
Text search:
Bharat
Biotech
Featured
Recommendations
4
New Publications
11
Language
Document type
No document type
14
Guidelines
13
Studies & Reports
6
Fact sheets
5
Strategic & Response Plan
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
16
Ukraine
2
Paraguay
2
Cameroon
1
Mozambique
1
Global
1
Africa
1
Latin America and the Carribbean
1
Germany
1
Brazil
1
Russia
1
Authors & Publishers
Publication Years
Category
COVID-19
12
Guidelines
6
Policies
4
Parasitology
3
Vaccine-preventable Diseases
2
Drugs & Medical Equipment
2
Studies & Reports
2
Malaria
2
Community Health
1
Virology
1
Community Health
1
Information, Education and Communication (IEC)
1
Diarrhoea
1
HIV & STI
1
Toolboxes
Immunization Guidelines
6
Covaxin
6
Country specific documents
3
Booster Doses
3
Country specific
2
Vaxzevria (Astra Zeneca)
2
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Pediatrics
1
Stroke
1
Clinical Guidelines
1
For Parents & Children
1
For Pregnant Women
1
Country Specific
1
Scientific & Research Studies
1
Access & Strategy
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Sputnik V
1
Inactivated COVID-19 Vaccines
1
Situation Reports & Updates
1
Guidelines & Manuals
1
General
1
Access to treatment and laboratory
1
Health Financing Toolbox
1
Women
1
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
2 April 2022
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Diarrhea is one of the world’s leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhea. Yet it can be prevented and treated. There is a vaccine. And while hundreds of thousands of children in India will gain access to rotavirus vaccines -part of a natio...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
Towards the Peoples Health Assembly Book -1
Towards the Peoples Health Assembly Book - 1
Emergency medical teams (EMTs) play an important role in strengthening health service networks in terms of their strategies and tactics for planning mass vaccination programs, especially in remote or under-resourced areas or those overwhelmed by COVID-19. EMTs experience deploying in remote areas an...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
